Riboflavin and its degradation product from Carthamus tinctorius
文献类型:期刊论文
作者 | Li Feng; He Zhisheng; Ye Yang![]() |
刊名 | Chinese Traditional and Herbal Drugs
![]() |
出版日期 | 2004 |
卷号 | 35期号:3页码:247-249 |
关键词 | Carthamus tinctorius L. Compositae riboflavin nucleoside |
ISSN号 | 0253-2670 |
其他题名 | 红花中核黄素及其降解产物 |
文献子类 | Article |
英文摘要 | Object To carry out a systematic study on the chemical constituents of Carthamus tinctorius L. In order to reveal pharmacological active compounds for their further development. Methods Three constituents were separated by macroporous resin, silica gel? polyamide, Sephadex LH-20 and spectral analysis. Results The structures were elucidated by spectroscopic means including ID, 2D NMR and ESI-MS; they are l-ribityl-2, 3-diketo-1, 2, 3, 4-tetrahydro-6, 7-dimethyl-quinoxaline ( I ), riboflavin ( I ) , and uracil-ribofuranose ( I ). Conclusion Compounds I - I are isolated from C tinctorius for the first time. Compound I is a very important coenzyme for our bodies. It has been found that compound I has the property of lowering the blood pressure of anesthetized dogs when administered in travenously. |
资助项目 | 国家自然科学基金资助项目[00000000] |
WOS研究方向 | General & Internal Medicine (provided by Clarivate Analytics) |
语种 | 中文 |
CSCD记录号 | CSCD:1611368 |
源URL | [http://119.78.100.183/handle/2S10ELR8/268383] ![]() |
专题 | 药物安全性评价中心 |
作者单位 | State Key Laboratory of Drug Research, Institute of Materia Medica, Shanghai Institute for Life Science, Chinese Academy of Sciences, Shanghai 201203, China. |
推荐引用方式 GB/T 7714 | Li Feng,He Zhisheng,Ye Yang. Riboflavin and its degradation product from Carthamus tinctorius[J]. Chinese Traditional and Herbal Drugs,2004,35(3):247-249. |
APA | Li Feng,He Zhisheng,&Ye Yang.(2004).Riboflavin and its degradation product from Carthamus tinctorius.Chinese Traditional and Herbal Drugs,35(3),247-249. |
MLA | Li Feng,et al."Riboflavin and its degradation product from Carthamus tinctorius".Chinese Traditional and Herbal Drugs 35.3(2004):247-249. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。